Bristol-Myers Squibb Company
COMPOUNDS USEFUL AS IMMUNOMODULATORS
Last updated:
Abstract:
The present disclosure generally relates to compounds useful as immunomodulators. Provided herein are compounds, compositions comprising such compounds, and methods of their use. The disclosure further pertains to pharmaceutical compositions comprising at least one compound according to the disclosure that are useful for the treatment of various diseases, including cancer and infectious diseases.
Status:
Application
Type:
Utility
Filling date:
19 Dec 2017
Issue date:
21 Nov 2019